AnaptysBio Inc sell JPMorgan Chase & Co.
Start price
13.04.23
/
50%
€19.70
Target price
13.04.24
€28.05
Performance (%)
1.02%
End price
14.04.24
€19.90
Summary
This prediction ended on 14.04.24 with a price of €19.90. With a performance of 1.02%, the SELL prediction by JPMorgan_Chase___Co_ for AnaptysBio Inc was trending in the wrong direction JPMorgan_Chase___Co_ has a follow-up prediction for AnaptysBio Inc, but this time predicts that AnaptysBio Inc is a Buy. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| AnaptysBio Inc | 5.115% | 5.115% | 159.189% | 211.027% |
| iShares Core DAX® | -2,68 % | 4,26 % | 2,12 % | 57,51 % |
| iShares Nasdaq 100 | 0,73 % | 5,80 % | 34,20 % | 92,83 % |
| iShares Nikkei 225® | -0,73 % | 9,32 % | 61,30 % | 80,34 % |
| iShares S&P 500 | 1,17 % | 5,48 % | 24,75 % | 70,97 % |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread AnaptysBio Inc diskutieren
AnaptysBio, Inc. (NASDAQ: ANAB) had its price target lowered by analysts at JPMorgan Chase & Co. from $32.00 to $31.00. They now have an "underweight" rating on the stock.
Ratings data for ANAB provided by MarketBeat
In the thread Trading AnaptysBio Inc
Die von JPMorgan_Chase___Co_ gewählte maximale Laufzeit wurde überschritten